Long-term follow up of interventional therapy of secundum atrial septal defect

Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD Ⅱ).Methods Between January 20...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chinese medical journal Jg. 125; H. 1; S. 149 - 152
Hauptverfasser: Yuan, Yi-Qiang, Huang, Qiong, Yu, Li, Wang, Rui-Min, Zhao, Yu-Jie, Guo, Ying-Xian, Sun, Jun-Hua, Niu, Si-Quan, Sun, Yun, Yang, Xing-Ming, Mao, You-Lin
Format: Journal Article
Sprache:Englisch
Veröffentlicht: China Department of Cardiology, Zhnengzhou Cardiovascular Hospital, Zhengzhou, Henan 450016, China 05.01.2012
Schlagworte:
ISSN:0366-6999, 2542-5641, 2542-5641
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD Ⅱ).Methods Between January 2001 and December 2005,61 patients underwent a successful percutaneous closure of ASD Ⅱ; including 25 male and 36 female.All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography,at intervals of 3 days,3 months,6 months,1 year,2 years,and 5 years after operation.Results Three days after percutaneous transcatheter septal closure (PTSC),the right atrium diameter,right ventricular end-diastolic left-right diameter and right ventricutar end-diastolic volume (RVEDV) decreased significantly (P 〈0.05).Right ventricular end-diastolic anteroposterior diameter (RVEDD),right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P〈0.01).During the period from 3 to 6 months,the size of the right atrium and right ventricle returned to normal range.Three days after PTSC,the left ventricular end-diastolic diameter (LVEDD),left ventricular end-diastolic volume (LVEDV),left ventricular end-systolic volume (LVESV),left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P 〈0.05).At 1 year,the size of the left atrium,left ventricle and left cardiac function returned to normal range (P 〈0.01).There were no deaths or significant complications during the study.At five year follow-up,all defects were completely closed and remained closed thereafter.Conclusion Transcatheter closure of ASD Ⅱ effectively eliminated the abnormal shunt and,subsequently improved the dimensions of each chamber and cardiac function.
AbstractList The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure. The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASDII). Between January 2001 and December 2005, 61 patients underwent a successful percutaneous closure of ASDII; including 25 male and 36 female. All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography, at intervals of 3 days, 3 months, 6 months, 1 year, 2 years, and 5 years after operation. Three days after percutaneous transcatheter septal closure (PTSC), the right atrium diameter, right ventricular end-diastolic left-right diameter and right ventricular end-diastolic volume (RVEDV) decreased significantly (P < 0.05). Right ventricular end-diastolic anteroposterior diameter (RVEDD), right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P < 0.01). During the period from 3 to 6 months, the size of the right atrium and right ventricle returned to normal range. Three days after PTSC, the left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P < 0.05). At 1 year, the size of the left atrium, left ventricle and left cardiac function returned to normal range (P < 0.01). There were no deaths or significant complications during the study. At five year follow-up, all defects were completely closed and remained closed thereafter. Transcatheter closure of ASDII effectively eliminated the abnormal shunt and, subsequently improved the dimensions of each chamber and cardiac function.
R541; Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD Ⅱ).Methods Between January 2001 and December 2005,61 patients underwent a successful percutaneous closure of ASD Ⅱ; including 25 male and 36 female.All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography,at intervals of 3 days,3 months,6 months,1 year,2 years,and 5 years after operation.Results Three days after percutaneous transcatheter septal closure (PTSC),the right atrium diameter,right ventricular end-diastolic left-right diameter and right ventricutar end-diastolic volume (RVEDV) decreased significantly (P <0.05).Right ventricular end-diastolic anteroposterior diameter (RVEDD),right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P<0.01).During the period from 3 to 6 months,the size of the right atrium and right ventricle returned to normal range.Three days after PTSC,the left ventricular end-diastolic diameter (LVEDD),left ventricular end-diastolic volume (LVEDV),left ventricular end-systolic volume (LVESV),left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P <0.05).At 1 year,the size of the left atrium,left ventricle and left cardiac function returned to normal range (P <0.01).There were no deaths or significant complications during the study.At five year follow-up,all defects were completely closed and remained closed thereafter.Conclusion Transcatheter closure of ASD Ⅱ effectively eliminated the abnormal shunt and,subsequently improved the dimensions of each chamber and cardiac function.
The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure. The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASDII).BACKGROUNDThe percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure. The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASDII).Between January 2001 and December 2005, 61 patients underwent a successful percutaneous closure of ASDII; including 25 male and 36 female. All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography, at intervals of 3 days, 3 months, 6 months, 1 year, 2 years, and 5 years after operation.METHODSBetween January 2001 and December 2005, 61 patients underwent a successful percutaneous closure of ASDII; including 25 male and 36 female. All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography, at intervals of 3 days, 3 months, 6 months, 1 year, 2 years, and 5 years after operation.Three days after percutaneous transcatheter septal closure (PTSC), the right atrium diameter, right ventricular end-diastolic left-right diameter and right ventricular end-diastolic volume (RVEDV) decreased significantly (P < 0.05). Right ventricular end-diastolic anteroposterior diameter (RVEDD), right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P < 0.01). During the period from 3 to 6 months, the size of the right atrium and right ventricle returned to normal range. Three days after PTSC, the left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P < 0.05). At 1 year, the size of the left atrium, left ventricle and left cardiac function returned to normal range (P < 0.01). There were no deaths or significant complications during the study. At five year follow-up, all defects were completely closed and remained closed thereafter.RESULTSThree days after percutaneous transcatheter septal closure (PTSC), the right atrium diameter, right ventricular end-diastolic left-right diameter and right ventricular end-diastolic volume (RVEDV) decreased significantly (P < 0.05). Right ventricular end-diastolic anteroposterior diameter (RVEDD), right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P < 0.01). During the period from 3 to 6 months, the size of the right atrium and right ventricle returned to normal range. Three days after PTSC, the left ventricular end-diastolic diameter (LVEDD), left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P < 0.05). At 1 year, the size of the left atrium, left ventricle and left cardiac function returned to normal range (P < 0.01). There were no deaths or significant complications during the study. At five year follow-up, all defects were completely closed and remained closed thereafter.Transcatheter closure of ASDII effectively eliminated the abnormal shunt and, subsequently improved the dimensions of each chamber and cardiac function.CONCLUSIONTranscatheter closure of ASDII effectively eliminated the abnormal shunt and, subsequently improved the dimensions of each chamber and cardiac function.
Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD Ⅱ).Methods Between January 2001 and December 2005,61 patients underwent a successful percutaneous closure of ASD Ⅱ; including 25 male and 36 female.All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography,at intervals of 3 days,3 months,6 months,1 year,2 years,and 5 years after operation.Results Three days after percutaneous transcatheter septal closure (PTSC),the right atrium diameter,right ventricular end-diastolic left-right diameter and right ventricutar end-diastolic volume (RVEDV) decreased significantly (P 〈0.05).Right ventricular end-diastolic anteroposterior diameter (RVEDD),right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P〈0.01).During the period from 3 to 6 months,the size of the right atrium and right ventricle returned to normal range.Three days after PTSC,the left ventricular end-diastolic diameter (LVEDD),left ventricular end-diastolic volume (LVEDV),left ventricular end-systolic volume (LVESV),left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P 〈0.05).At 1 year,the size of the left atrium,left ventricle and left cardiac function returned to normal range (P 〈0.01).There were no deaths or significant complications during the study.At five year follow-up,all defects were completely closed and remained closed thereafter.Conclusion Transcatheter closure of ASD Ⅱ effectively eliminated the abnormal shunt and,subsequently improved the dimensions of each chamber and cardiac function.
Author YUAN Yi-qiang HUANG Qiong YU Li WANG Rui-min ZHAO Yu-jie GUO Ying-xian SUN Jun-hua NIU Si-quan SUN Yun YANG Xing-ming MAO You-lin
AuthorAffiliation Department of Cardiology, Zhnengzhou Cardiovascular Hospital, Zhengzhou, Henan 450016, China
AuthorAffiliation_xml – name: Department of Cardiology, Zhnengzhou Cardiovascular Hospital, Zhengzhou, Henan 450016, China
Author_xml – sequence: 1
  givenname: Yi-Qiang
  surname: Yuan
  fullname: Yuan, Yi-Qiang
  email: yiqiangyuan@hotmail.com
  organization: Department of Cardiology, Zhengzhou Cardiovascular Hospital, Zhengzhou, Henan 450016, China. yiqiangyuan@hotmail.com
– sequence: 2
  givenname: Qiong
  surname: Huang
  fullname: Huang, Qiong
– sequence: 3
  givenname: Li
  surname: Yu
  fullname: Yu, Li
– sequence: 4
  givenname: Rui-Min
  surname: Wang
  fullname: Wang, Rui-Min
– sequence: 5
  givenname: Yu-Jie
  surname: Zhao
  fullname: Zhao, Yu-Jie
– sequence: 6
  givenname: Ying-Xian
  surname: Guo
  fullname: Guo, Ying-Xian
– sequence: 7
  givenname: Jun-Hua
  surname: Sun
  fullname: Sun, Jun-Hua
– sequence: 8
  givenname: Si-Quan
  surname: Niu
  fullname: Niu, Si-Quan
– sequence: 9
  givenname: Yun
  surname: Sun
  fullname: Sun, Yun
– sequence: 10
  givenname: Xing-Ming
  surname: Yang
  fullname: Yang, Xing-Ming
– sequence: 11
  givenname: You-Lin
  surname: Mao
  fullname: Mao, You-Lin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22340483$$D View this record in MEDLINE/PubMed
BookMark eNo9kMlOwzAURS1URAf4BRQ2wCbBdmwnXqKKSapgA-vIcew2UWKnsUNVvh5XLayu9N55g84cTIw1CoB7BJM0Y_BBdiJpkto5k8CUsZhxzhMMEU4gSiDOz8AMU4JjygiagNk_MwVz5xoIMaUZuwBTjFMCSZ7OwPvKmnXs1dBF2rat3UVjH1kd1SbUvpXxtTWijfxGDaLfHzpOydFUYxcJP9Sh5VTvQ1RKK-kvwbkWrVNXp1yAr-enz-VrvPp4eVs-rmKJWeZjWmqmsjLnZUVQCiXKOK8grnKsuUCSUI1LiXOGKIeIcySEgnmVI0YyEkZEugC3x707YbQw66Kx4xAedcXPRnbNQQlEQUgA745gP9jtqJwvutpJ1bbCKDu6gmNMIUspDeT1iRzLTlVFP9SdGPbFn6sA3BwBuQnOtnW4-scQGMRShNNfn558RQ
ClassificationCodes R541
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3760/cma.j.issn.0366-6999.2012.01.028
DatabaseName 中文科技期刊数据库
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Long-term follow up of interventional therapy of secundum atrial septal defect
EISSN 2542-5641
EndPage 152
ExternalDocumentID zhcmj201201028
22340483
40557512
Genre Journal Article
GroupedDBID ---
-05
-0E
-SE
-S~
.55
.GJ
29B
2B.
2C~
2RA
2WC
3V.
40I
53G
5GY
5RE
5VR
5VS
6J9
7X7
88E
8FI
8FJ
92F
92I
92L
92M
93N
93R
9D9
9DE
AAHPQ
AASCR
ABASU
ABCQX
ABDIG
ABUWG
ABVCZ
ABXLX
ACGFO
ACGFS
ACILI
ADGGA
ADHPY
ADPDF
ADRAZ
AENEX
AFDTB
AFKRA
AFUIB
AHMBA
AHVBC
AINUH
AJIOK
AJNWD
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
ANFDX
AOHHW
BENPR
BPHCQ
BVXVI
C1A
CAJEE
CAJUS
CCEZO
CCPQU
CHBEP
CIEJG
CQIGP
CW9
DIK
DIWNM
EBS
EEVPB
EJD
F5P
FA0
FCALG
FRP
FYUFA
GNXGY
GQDEL
GROUPED_DOAJ
GX1
HLJTE
HMCUK
HYE
IAO
IHR
IHW
IKREB
INH
INR
IPNFZ
ITC
JUIAU
KQ8
L7B
M1P
M48
OK1
OPUJH
OVD
OVDNE
OVEED
OXXIT
P2P
P6G
PIMPY
PQQKQ
PROAC
PSQYO
PV9
Q--
Q-4
R-E
RIG
RLZ
RNS
RPM
RT5
RZL
S..
T8U
TCJ
TEORI
TGQ
TR2
TSPGW
U1F
U1G
U5E
U5O
UKHRP
W2D
W91
WFFXF
X7J
X7M
XSB
ZA5
ZGI
ZXP
~WA
0R~
AAAAV
AAIQE
ABZZY
ACXJB
AFBFQ
AHQNM
AJCLO
AJZMW
AKCTQ
ALIPV
ALKUP
AOQMC
BQLVK
CGR
CUY
CVF
ECM
EIF
H13
NPM
OVT
PHGZM
PHGZT
PJZUB
PPXIY
7X8
ADKSD
4A8
PMFND
PSX
ID FETCH-LOGICAL-c267t-5bf6e7b89bd4130c1799d02d82f9a1c45f2bc28615901991aae08d816474bd4a3
ISICitedReferencesCount 8
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000300749400028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0366-6999
2542-5641
IngestDate Thu May 29 03:55:55 EDT 2025
Thu Oct 02 10:47:17 EDT 2025
Mon Jul 21 06:02:08 EDT 2025
Wed Feb 14 10:47:42 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords congenital heart disease
atrial
interventional
heart septal defects
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c267t-5bf6e7b89bd4130c1799d02d82f9a1c45f2bc28615901991aae08d816474bd4a3
Notes 11-2154/R
congenital heart disease; heart septal defects; atrial; interventional
Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The aim of this study was to assess long-term results of percutaneous closure of secundum-type atrial septal defect (ASD Ⅱ).Methods Between January 2001 and December 2005,61 patients underwent a successful percutaneous closure of ASD Ⅱ; including 25 male and 36 female.All were included in the patient study and were followed up to monitor by electrocardiogram and echocardiography,at intervals of 3 days,3 months,6 months,1 year,2 years,and 5 years after operation.Results Three days after percutaneous transcatheter septal closure (PTSC),the right atrium diameter,right ventricular end-diastolic left-right diameter and right ventricutar end-diastolic volume (RVEDV) decreased significantly (P 〈0.05).Right ventricular end-diastolic anteroposterior diameter (RVEDD),right ventricular end-systolic volume (RVESV) and right ventricular ejection fraction (RVEF) also decreased (P〈0.01).During the period from 3 to 6 months,the size of the right atrium and right ventricle returned to normal range.Three days after PTSC,the left ventricular end-diastolic diameter (LVEDD),left ventricular end-diastolic volume (LVEDV),left ventricular end-systolic volume (LVESV),left ventricular-systolic volume (LVSV) and left ventricular ejection fraction (LVEF) were significantly increased (P 〈0.05).At 1 year,the size of the left atrium,left ventricle and left cardiac function returned to normal range (P 〈0.01).There were no deaths or significant complications during the study.At five year follow-up,all defects were completely closed and remained closed thereafter.Conclusion Transcatheter closure of ASD Ⅱ effectively eliminated the abnormal shunt and,subsequently improved the dimensions of each chamber and cardiac function.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 22340483
PQID 922506355
PQPubID 23479
PageCount 4
ParticipantIDs wanfang_journals_zhcmj201201028
proquest_miscellaneous_922506355
pubmed_primary_22340483
chongqing_primary_40557512
PublicationCentury 2000
PublicationDate 2012-01-05
PublicationDateYYYYMMDD 2012-01-05
PublicationDate_xml – month: 01
  year: 2012
  text: 2012-01-05
  day: 05
PublicationDecade 2010
PublicationPlace China
PublicationPlace_xml – name: China
PublicationTitle Chinese medical journal
PublicationTitleAlternate Chinese Medical Journal
PublicationTitle_FL Chinese Medical Journal
PublicationYear 2012
Publisher Department of Cardiology, Zhnengzhou Cardiovascular Hospital, Zhengzhou, Henan 450016, China
Publisher_xml – name: Department of Cardiology, Zhnengzhou Cardiovascular Hospital, Zhengzhou, Henan 450016, China
SSID ssj0025576
Score 1.9535284
Snippet Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The aim...
The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure. The aim of this...
R541; Background The percutaneous transcatheter closure of secundum atrial septal defect (ASD) is increasingly a widespread alternative to surgical closure.The...
SourceID wanfang
proquest
pubmed
chongqing
SourceType Aggregation Database
Index Database
Publisher
StartPage 149
SubjectTerms Adolescent
Adult
Child
Child, Preschool
Female
Follow-Up Studies
Heart Septal Defects, Atrial - diagnostic imaging
Heart Septal Defects, Atrial - surgery
Humans
Male
Middle Aged
Ultrasonography
Young Adult
介入治疗
右心室
孔型
左心室
房间
继发
缺损
超声心动图
Title Long-term follow up of interventional therapy of secundum atrial septal defect
URI http://lib.cqvip.com/qk/85656X/201201/40557512.html
https://www.ncbi.nlm.nih.gov/pubmed/22340483
https://www.proquest.com/docview/922506355
https://d.wanfangdata.com.cn/periodical/zhcmj201201028
Volume 125
WOSCitedRecordID wos000300749400028&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2542-5641
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0025576
  issn: 0366-6999
  databaseCode: DOA
  dateStart: 20000101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLe2gSYuaHx3wMgBS0iVtzTNh31suhQOowK0SR2XKB9O24k6XduMaX89z7HjtghpcOASWX4vser3q9-z_T4Qel-4XprxgpPcDXLi-pSRxC26pMMKnyVOChqF1sUmguGQjkbsy87uQRMLc_MjEILe3rL5fxU19IGwZejsP4jbfBQ6oA1ChyeIHZ5_JfizUoyJXHDbBci4_Nmu5k1eiMWGg7nKJiApS55VIpdOyqqEx5LPZYRkzqWnx6bxiiMXhxT3TnHkYXqKaVQ3-jgMZQP6ez6OfMyA5MiecIBZgKMBDvuYUhxRTEMcdmoeH1MgBZiymqR4zKnE5UVv2L6ckmtA79hADzo_tr_CDxiv-dpnU6NYJPlbNSUznU5cn2bUbiHE9tYuKaCDF6vGDaJfu-Q2QTvfJ4KL8d2krDTB-Oo2JVYUl2ZSqlvAKul6dn1E0V_XJDchYz7xmarQZNSBCsTewr1a3Dsquaq2Ezoq8-7vKkg6GQFEsllyfFWPcmxGkY6EjkoSS9fq1zhF3k2y2ZVkkWn-6C564AQeY80pgT5D8LxAX7-rb-6jD3rQk_uGlNlDJiCha7CJ_rSfqsPWRAFi3bCwzg_QY701snoK0k_QDhdP0f5n7fzxDA0Nsi2FbKuaW2VhbSPb0siWlAbZlkK2pZBtKWQ_RxeD6Lz_iehyICRz_GBFvLTweZBSlubS8spkLsPcdnLqFCzpZK5XOGnmUDDRwcaFbU-ScJvmVCbMc-GVpPsC7YlS8FfIYo70OEi6Hk1SN3VSyus7yCBlnHUL326hQzNV8VylfYldma4O7OMWspq5i2EtlhdsieBltYwZKEdbWvAt9FLNqXkZrHBXVm9ooXd6kmO9ZizjbcEf3svxGj1a_3XeoL3VouJv0cPsZjVdLo7QbjCiRzVqfgEfgK7V
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long-term+follow+up+of+interventional+therapy+of+secundum+atrial+septal+defect&rft.jtitle=%E4%B8%AD%E5%8D%8E%E5%8C%BB%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%88%E8%8B%B1%E6%96%87%E7%89%88%EF%BC%89&rft.au=YUAN+Yi-qiang&rft.au=HUANG+Qiong&rft.au=YU+Li&rft.au=WANG+Rui-min&rft.date=2012-01-05&rft.pub=Department+of+Cardiology%2C+Zhnengzhou+Cardiovascular+Hospital%2C+Zhengzhou%2C+Henan+450016%2C+China&rft.issn=0366-6999&rft.volume=125&rft.issue=1&rft.spage=149&rft.epage=152&rft_id=info:doi/10.3760%2Fcma.j.issn.0366-6999.2012.01.028&rft.externalDocID=zhcmj201201028
thumbnail_s http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85656X%2F85656X.jpg
http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzhcmj%2Fzhcmj.jpg